Manage Your Liver
Q:

Why does the current hepatitis B drug treatment have serious deficiencies?

Why does the current hepatitis B drug treatment have serious deficiencies?
A:

The current medication for hepatitis B may be able to stop virus replication, but there are also some major shortcomings, mainly due to the toxicity of the drug itself.1 In addition, the patient is required to use the drug for a long period without stopping. Besides, the medication cannot prevent liver fibrosis and does not contribute to liver health protection.2 So what can chronic hepatitis B patients do to make up for these shortcomings? Is a better or more comprehensive treatment possible?

 

Chronic hepatitis B is a common liver disease where the hepatitis virus continuously replicates in the body, attacking the liver and leading to chronic inflammation. Patients normally have a high level of liver enzymes (ALT & AST). Now, the current main stream treatment is to use medication to control the replication of hepatitis virus, so that the virus count lowers, thereby reducing the attacks and inflammation of the liver. 3

 

It has to be made clear that the only purpose of this medication is to limit and stop viral replication, meaning that it does not and cannot cure the disease. Moreover, the patient is required to take the medication for life, because once it is stopped, the virus will resume its replication. Also, the medication does not promote recovery of liver cells, meaning that the inflammation or damage done remains until the liver is repaired by itself. Most importantly, using the medication does not guarantee that liver function will return to normal as this depends on the liver’s  own recovery ability.

 

Another obvious downside of the drug is that like all other drugs, it contains toxicity. Long-term use will definitely pose adverse effect on human health, especially the liver, since it is the main organ responsible for the decomposition of toxins. 4

 

The disadvantages of using medication to treat chronic hepatitis B are evident; therefore measures to make up for these shortcomings should be incorporated into the treatment program to make it more all-rounded. Patients are recommended to enhance their liver’s self-healing ability and to adopt protective measures to guard liver health. Only by doing these can patients ensure their liver cells are protected from injuries caused by long term medications, not suffer from any side effects of the drugs and prevent liver fibrosis, cirrhosis and other chronic liver diseases

 

Click for more information about enhancing liver’s self-healing ability and protection.

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
ALT (Alanine Aminotransferase / SGPT) is an enzyme that is mainly found in liver cells. The level of ALT in our bloodstream is the primary indicator of liver health. Multiple studies have demonstrated that the presence of an elevated ALT level is associated with increased liver-related mortality.   New normal ALT level issued The American College of Gastroenterology (ACG) recently issued a new Practice Guideline that aims to offer a framewor
A:
ALT (Alanine Aminotransferase / SGPT) is an enzyme that is mainly found in liver cells. The level of ALT in our bloodstream is the primary indicator of liver health.   What does high ALT indicate? ALT enzymes are normally contained within liver cells when the liver is healthy, but when the liver cells are injured or damaged by whatever means, ALT enzymes are released into the bloodstream, causing levels to go up. Therefore, by measuring the
Hit Questions
A:
YHK has significant effect in stopping liver inflammation; it can enhance the recovery of liver health and protect liver cells. Those who have experienced YHK often have these questions in mind: Why is YHK so different from other liver medicines and supplements? Why is it possible to have such unprecedented effects? The answer seems magical, but in fact, it is not complicated - Because YHK possesses a perfect balance.   To explain this, we must first point out that YH
A:
You probably have already heard about the new antiviral hep C drug, which is effective but insanely expensive. It claims to have around 90% success rate, that’s why so many hepatitis C patients are dying for it even though it’s extremely costly. But apart from its expensive price tag, there is a bigger issue behind this new drug that not many people know about. Scientists and researchers have found an increased risk of extreme liver cancer related to this new drug after successful
A:
Hepatitis C is a wide spread and deadly disease affecting an estimated of 3.5 million Americans.   Treatment for hepatitis C has evolved over the years, going from highly toxic drugs involving injections with horrible side effects, to medications with minimal side effects. Success rate of treatment options has also improved greatly Although the high price tag of the new DAA treatment is controversial, it has undoubtedly helped to cure many hepatitis C patients.
A:
“It isn't fat but rather fibrosis that drives disease progression in people with advanced non-alcoholic steatohepatitis (NASH).”   NASH is one of the most prevalent liver diseases nowadays. NASH is related to non-alcoholic fatty liver disease (NAFLD) which is characterized by the buildup of fat in the liver. Although it is normal to have some fat in the liver, some people might develop inflammation because of this fat accumulation, this is cal
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us